Drug Neurology

Briviact

Payments companies reported to CMS as associated with Briviact. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3.0Massociated payments (2023-2025)
10,929clinicians with associated payments
2companies reporting

By year

2023 $1.1M
2024 $1.3M
2025 $650K

Payments reported as associated with Briviact, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $1.3M
Neurology With Special Qualifications In Child Neurology $359K
Epilepsy $234K
Family $199K
Vascular Neurology $158K
Physician Assistant $112K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Briviact

These are the largest totals companies reported as associated with Briviact. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Brandon Foreman Cincinnati, OH Neurology (Psychiatry & Neurology) $155,141.91
Mounzer Yassin Kassab East Lansing, MI Vascular Neurology $146,906.55
Tricia Ting Washington, DC Neurology (Psychiatry & Neurology) $71,668.35
Suad Khalil East Lansing, MI Neurology With Special Qualifications In Child Neurology $64,968.68
David Burdette Grand Rapids, MI Epilepsy $63,224.20
Atiya Khan Fort Wayne, IN Neurology With Special Qualifications In Child Neurology $62,915.76
John Ingram Jackson, MS Neurology With Special Qualifications In Child Neurology $50,329.56
Erasmo Passaro St Petersburg, FL Neurology (Psychiatry & Neurology) $48,303.03
Premkumar Nattanmai Chandrasekaran Columbia, MO Neurocritical Care $46,474.37
Tariq Gheith East Lansing, MI Neurology (Psychiatry & Neurology) $43,374.35

Prescribed Briviact?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.